Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Cerebrovascular Diseases (Basel, Switzerland)|December 11, 2012
Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registryWondwossen G Tekle, Saqib A Chaudhry, Ameer E Hassan, et al.
BMC Medical Genetics|May 12, 2009
Suggestion for linkage of chromosome 1p35.2 and 3q28 to plasma adiponectin concentrations in the GOLDN StudyLaura J Rasmussen-Torvik, James S Pankow, James M Peacock, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 11, 2012
Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans--Atherosclerosis Risk in Communities (ARIC) studyJeffrey R Misialek, Faye L Lopez, Pamela L Lutsey, et al.
American Heart Journal|September 29, 2014
The impact of prolonged lower limb ischemia on amputation, mortality, and functional status: the FRIENDS registrySue Duval, Hong H Keo, Niki C Oldenburg, et al.
Diabetes Care|February 21, 2008
Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN studyJian Shen, Donna K Arnett, Laurence D Parnell, et al.
BMC Cardiovascular Disorders|December 21, 2013
The FReedom from Ischemic Events-New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery diseaseHong H Keo, Sue Duval, Iris Baumgartner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 14, 2007
Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN studyChao-Qiang Lai, Donna K Arnett, Dolores Corella, et al.
European Journal of Human Genetics : EJHG|January 24, 2008
The genetic architecture of fasting plasma triglyceride response to fenofibrate treatmentJennifer A Smith, Donna K Arnett, Reagan J Kelly, et al.
The Journal of Nutrition|July 20, 2007
Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndromeJian Shen, Donna K Arnett, James M Peacock, et al.
Atherosclerosis|February 22, 2005
Evidence for a gene influencing fasting LDL cholesterol and triglyceride levels on chromosome 21qKari E North, Michael B Miller, Hilary Coon, et al.
Pageof 4